Shanghai Desano Chemical Pharmaceutical Co., Ltd., Pudong District, China – FDA Inspections

Inspection records and compliance data for Shanghai Desano Chemical Pharmaceutical Co., Ltd. in Pudong District. 5 FDA inspections on record (1 OAI), 2 Form 483s, last inspected November 17, 2023.

Company Profile

This profile covers Shanghai Desano Chemical Pharmaceutical Co., Ltd. based in Pudong District, China.

FDA Inspection History

FDA inspections: 5
OAI: 1
VAI: 3
NAI: 1
Form 483s: 2
Warning letters: 0

First inspected April 24, 2009. Last inspected November 17, 2023.

FDA inspections (5)

Date	Result	FDA center(s)	Insp. #
November 17, 2023	VAI	Human Drugs · Drug Quality Assurance	1225414
March 10, 2017	VAI	Human Drugs · Drug Quality Assurance	1009779
May 7, 2015	OAI	Human Drugs · Drug Quality Assurance	926398
June 7, 2012	NAI	Human Drugs · Drug Quality Assurance	790434
April 24, 2009	VAI	Human Drugs · Drug Quality Assurance	601220

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Zhejiang Raybow Pharmaceutical Co., Ltd.

Shandong Topscience Bio-Tech Co., Ltd.

Hunan Er-Kang Pharmaceutical Co., Ltd.

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd

Ruyuan Hec Pharm Co. Ltd.

Anhui Fengle Perfume Co., Ltd.

Weifang Shengtai Medicine Co., Ltd.

Jiangxi Starry Pharmaceutical Co., Ltd

Zhejiang Supor Pharmaceuticals Co., Ltd.

Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.